82
Participants
Start Date
December 31, 2020
Primary Completion Date
September 4, 2024
Study Completion Date
September 4, 2024
LUM-201
Administered orally once daily
rhGH Norditropin® pen (34 µg/kg)
Administered subcutaneously (s.c., under the skin) once daily.
Canberra Hospital, Garran
Royal Children's Hospital, Melbourne
Department of Pediatrics and Endocrinology- Monash Health, Clayton
Wellington Regional Hospital CCDHB, Newtown
NYU Grossman School of Medicine, New York
UBMD Pediatrics, Buffalo
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Penn State College of Medicine, Hershey
The Children's Hospital of Philadelphia, Philadelphia
Children's National Hospital, Washington D.C.
University of Virginia Health System, Charlottesville
Medical University of South Carolina, Charleston
The Mount Sinai Hospital, Mount Sinai
Atlanta Diabetes Associates, Atlanta
Novak Center For Childrens Health, Louisville
Nationwide Children's Hospital, Columbus
Indiana University School of Medicine, Indianapolis
University of Iowa, Iowa City
Children's Minnesota, Saint Paul
M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic, Minneapolis
The Children's Mercy Hospital, Kansas City
University of Oklahoma Health Sciences Center, Pediatric Diabetes and Endocrinology, Oklahoma City
Cook Children's Medical Center, Fort Worth
Diabetes & Glandular Disease Clinic, P.A., San Antonio
Texas Tech University Health Sciences Center, Amarillo
Pediatric Endocrine Associates, Greenwood Village
Rady Children's Hospital, San Diego
Center of Excellence in Diabetes and Endocrinology, Sacramento
Seattle Children's Hospital, Seattle
MultiCare Institute for Research and Innovation, Tacoma
Schneider Children's Medical Center Institute for Endocrinology and Diabetes National Center, Petah Tikva
UMass Memorial Medical Center, Worcester
Queensland Children's Hospital, South Brisbane
Liggins Institute, University of Auckland, Auckland
Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdziałem Kardiologii, Uniwersytecki Dziecięcy Szpital Kliniczny im.Ludwika Zamenhofa w Białymstoku, Bialystok
Klinika Endokrynologii i Chorob Metabolicznych, Instytut Centrum Zdrowia Matki Polki, Lodz
Klinika Pediatrii, Diabetologii i Endokrynologii Gdansk, Pomorskie
klinika Pediatrii, Endokrynologii i Diabetologii Dziecięcej, Rzeszów
Sonomed - Centrum Medyczne, Szczecin
"Klinika Endokrynologii i Diabetologii, Instytut Pomnik Centrum Zdrowia Dziecka", Warsaw
SP Dziecięcy Szpital Kliniczny w Warszawie, Warsaw
Klinika Endokrynologii i Diabetologii Wieku Rozwojowego UM, Wroclaw
State Institution 'V. P. Komissarenko Institute of Endocrinology and Metabolism of the National academy of medical science of Ukraine, Kyiv
Lead Sponsor
Lumos Pharma
INDUSTRY